High-Dose radiation blasts prostate tumors in new pilot study
NCT ID NCT04147806
First seen Apr 14, 2026 · Last updated May 23, 2026 · Updated 6 times
Summary
This early-phase study tests whether giving very high doses of radiation in just 1 or 5 sessions can safely control intermediate-risk prostate cancer. Thirty-one men will receive either a single 24 Gy dose or five 9 Gy doses using advanced image-guided technology. The main goal is to check for serious side effects within 3 months, with follow-up over 5 years to monitor PSA levels and tumor response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Montefiore Medical Center - Moses Campus
The Bronx, New York, 10467-2490, United States
Conditions
Explore the condition pages connected to this study.